MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Comparison of thermal sensation and pain thresholds in LRRK2 carriers and non carriers with Parkinson’s disease

    A. Khlebtovsky, Y. Roditi, R. Djaldetti (Petach Tikva, Israel)

    Objective: To compare between clinical findings and quantitative sensory testing (QST) data in patients with Parkinson's disease (PD) positive and negative for mutations in LRKK2.…
  • 2018 International Congress

    Acid sphingomyelinase deficiency rescues mitochondrial dysfunction in gba-/- zebrafish (Danio rerio)

    M. Keatinge, L. Trollope, H. Mortiboys, O. Bandmann (Sheffield, United Kingdom)

    Objective: To determine the interaction between glucocerebrosidase deficiency and acid sphingomyelinase deficiency in a tractable vertebrate model system of Parkinson's disease. Background: Heterozygous glucocerebrosidase (GBA)…
  • 2018 International Congress

    Tef polymorphism predicts the decline of sleep disturbances in Parkinson’s disease

    P. Hua, W. Liu (Nanjing, China)

    Objective: Circadian dysfunction may contribute to the etiology of motor and non-motor symptoms of Parkinson’s disease (PD). The influence of polymorphisms of Cry1 rs2287161, Cry2…
  • 2018 International Congress

    eEF1A2 and Prdx1 as possible new targets for Parkinson’s disease therapeutics

    W. Wirakiat, P. Dharmasaroja (Bangkok, Thailand)

    Objective: We investigated expression of eEF1A2 and Prdx1 in differentiated SH-SY5Y cells in searching for possible new targets for Parkinson’s disease treatment. Background: Parkinson’s disease…
  • 2018 International Congress

    Investigating the influence of alpha-synuclein promoter (Rep1) polymorphism on cognition, disability and plasma alpha-synuclein levels in Parkinson’s disease

    YJ. Tan, Y. Zhao, ZH. Lu, S. Ng, E. Ng, F. Setiawan, WL. Au, EK. Tan, L. Tan, A. Ng (Singapore, Singapore)

    Objective: We sought to investigate the relationship between SNCA Rep1 allele length and cognitive, motor and disability scores in PD, as well with plasma alpha-synuclein…
  • 2018 International Congress

    Automated Differential Diagnosis of Parkinsonian Syndromes Using FDG-PET Metabolic Brain Network Analysis

    T. Rus, P. Tomše, L. Jensterle, M. Grmek, Z. Pirtošek, D. Eidelberg, C. Tang, M. Trošt (Ljubljana, Slovenia)

    Objective: To discriminate among parkinsonian patients using an automated network analysis of FDG-PET brain images. Background: Clinical differentiating among parkinsonian syndromes: Parkinson’s disease (PD), multiple…
  • 2018 International Congress

    Longitudinal decline in white matter integrity in Parkinson’s disease: An analysis of Parkinson Progression Markers Initiative diffusion tensor imaging data

    K. Taylor, F. Sambataro, A. Bertolino, J. Dukart (Basel, Switzerland)

    Objective: To determine the relative changes in white matter integrity as measured by diffusion tensor imaging (DTI) magnetic resonance imaging (MRI) in PD patients relative…
  • 2018 International Congress

    Structural neural correlates of independent gait domains in Parkinson’s disease

    J. Wilson, B. Galna, S. Lord, A. Yarnall, R. Lawson, G. Duncan, T. Khoo, D. Burn, L. Rochester, J.P. Taylor (Newcastle upon Tyne, United Kingdom)

    Objective: To assess the subcortical motor structures of the brain associated with independent gait domains from Lord et al’s gait models (1, 2), in Parkinson’s…
  • 2018 International Congress

    Striatal dopamine uptake and olfactory dysfunction in patients with early Parkinson’s disease

    YS. Oh, DW. Ryu, JS. Kim, CH. Lyoo (Seoul, Republic of Korea)

    Objective: To identify dopamine transporter status of corpus striatum and thalamus using magnetic resonance imaging-guided spatial normalization method in patients with PD according to olfactory…
  • 2018 International Congress

    Hypometabolism of the posterior parietal cortex in PD with dementia: [18F]FDG PET study

    N.R. Choi, K.W. Park, M.S. Kim, J.H. Ko, S.J. Kim, S.J. Chung, C.S. Lee (Seoul, Republic of Korea)

    Objective: To investigate the neuroimaging marker for dementia in Parkinson’s disease (PD) patients using [18F]FDG PET. Background: Dementia may occur in patients with PD during…
  • « Previous Page
  • 1
  • …
  • 139
  • 140
  • 141
  • 142
  • 143
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley